VeDA Names Recipients of Champion of Vestibular Medicine Award Initiative
The Vestibular Disorders Association (VeDA) has named the recipients of its 2024 Lifetime Achievement Awards.
Category: Hearing Loss
Hearing Loss
Latest
Hearing Loss
Latest
VeDA to Spotlight Vestibular Disorders During Balance Awareness Week
The Vestibular Disorder Association is hosting Balance Awareness Week to raise awareness of vestibular disorders and offer patient resources.
Hearing Loss
Latest
Beyond Hearing Screening: The Importance of Holistic Hearing Care and Audiometric Analysis
For patients to get the most out of hearing screenings, the service should ensure a path to further diagnosis and appropriate follow-up care.
Patient Care
Latest
Phonak Details Upcoming International Pediatric Conference
The International Pediatric Conference, to be held this October 2024, will bring together global experts to discuss childhood hearing loss.
Hearing Disorders
Latest
Sensorineural Hearing Loss Treatment Project Selected for Pilot Program
The Ear Science Institute Australia's project on sensorineural hearing loss treatment will receive research support from MedChem Australia.
Tinnitus
Latest
Neuromod Partners with University of South Dakota Clinic to Provide Tinnitus Treatment
Neuromod Devices is expanding access to its Lenire bimodal neuromodulation device, addressing the demand for effective tinnitus treatment.
Prevention
Latest
Gamers Risk Hearing Loss But Are Open to Safe Listening Features
Over 75% of video gamers regularly engage in activities harmful to their hearing, according to results of a new poll.
Vestibular Care
Latest
Radiomics Can Predict Hearing Conditions in Vestibular Schwannoma Patients
A recent study demonstrates that radiomics imaging analysis can predict the hearing status of patients with vestibular schwannoma.
Health & Wellness
Latest
Acousia to Present PROHEARÂ Study on Hearing Loss Treatment for Cancer Patients
The PROHEAR study is a placebo-controlled Phase 2a study investigating the otoprotective efficacy of ACOU085 in patients with testicular cancer undergoing cisplatin-based chemotherapy.